Recently, defects or aberrant expressions of subunits in COX have been associated with clinical prognosis in several types of cancers, including colorectal cancer, glioma, breast and hepatoma [17,18,19,20,21]. The gene discussed is COX5A; the disease is hepatocellular carcinoma.